The Scleroderma FAQ™ is a comprehensive overview of systemic sclerosis (SSc) diagnosis and treatment. Key topics covered in the FAQ include:
- Differential diagnosis
- Scleroderma symptoms
- Scleroderma antibodies
- Pregnancy and scleroderma
- Standard systemic treatments
- Experimental systemic treatments
- Symptom-focused treatments
These articles discuss SSc-related ANA and antibody testing topics such as: false-negative ANA problems with ELISA and Multiplex testing, changes in ANA and antibody levels over time, ANA-negative SSc, and false positive Scl-70 (topoisomerase) results.
Topics include: 1) understanding the 2013 ACR/EULAR Classification Criteria for SSc diagnosis, 2) current EULAR evidence-based recommendations for the treatment of SSc, and 3) suggested Guidelines for individual trials of therapeutic plasma exchange (TPE) for treating SSc.
If you are working with a newly diagnosed systemic scleroderma patient, some of these articles may be useful to print out and give to your patients, including:
- Guide for New and Future Patients
- Guide for Family and Friends (Future Publication)
- Yes, you do have internal organ involvement, but…
- Scleroderma: know your terms and your antibody type
- Understanding Medical Research